KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : 류백렬
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 29건 중 2-29 번을 표시중입니다.
2
Article
Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index < 55%: single-arm phase II study
김규표
;
김용일
;
류백렬
;
et al
2021
3
Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
김규표
;
류백렬
;
방경혜
;
et al
2021
4
Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma
강효정
;
김강모
;
김규표
;
et al
2021
5
Article
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study
김강모
;
김좌훈
;
류백렬
;
et al
2021
6
Article
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
김규표
;
류백렬
;
박준오
;
et al
2021
7
Article
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
류백렬
;
박숙련
;
Beatriz Lopez
;
et al
2021
8
Article
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
김규표
;
류백렬
;
박도현
;
et al
2021
9
Article
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240
류백렬
;
Abby B Siegel
;
Amit S Kulkarni
;
et al
2021
10
Article
Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience
김형돈
;
류백렬
;
방영학
;
et al
2021
11
Article
Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinoma
김강모
;
김지윤
;
류백렬
;
et al
2021
12
Article
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
강명주
;
강병욱
;
김경원
;
et al
2021
13
Article
Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival
권재우
;
김규표
;
김송철
;
et al
2021
14
Article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer
강지훈
;
김규표
;
김송철
;
et al
2021
15
Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial
류백렬
;
Chao Y.
;
Chen E.
;
et al
2021
16
Article
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
강윤구
;
국명철
;
김균지
;
et al
2021
17
Article
Prognostic Value of 18F-FDG PET in Neuroendocrine Neoplasm
김태형
;
류백렬
;
류진숙
;
et al
2021
18
Article
Radiation therapy for recurrent extrahepatic bile duct cancer
고민지
;
김규표
;
김종훈
;
et al
2021
19
Article
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
류백렬
;
Ann-Li Cheng
;
Chia Jui Yen
;
et al
2021
20
Article
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)
류백렬
;
Andres J Munoz Martin
;
Charles D Lopez
;
et al
2021
21
Article
Real-world data analysis of patients with cancer of unknown primary
강소라
;
김규표
;
김정은
;
et al
2021
22
Article
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
김형돈
;
류백렬
;
방영학
;
et al
2021
23
Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib
김형돈
;
류백렬
;
방영학
;
et al
2021
24
Article
Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis
김형돈
;
류백렬
;
박숙련
;
et al
2021
25
Article
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3(-) CD4(+) T Cells in Biliary Tract Cancer
김규표
;
김기훈
;
김단비
;
et al
2021
26
Article
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
김승태
;
류백렬
;
배우균
;
et al
2021
27
Article
Value of 18F-FDG PET in Neuroendocrine Neoplasm: A Systematic Review and Meta-analysis
김태형
;
류백렬
;
류진숙
;
et al
2021
28
Dissertation
담도암 환자로부터 암세포주와 이종이식의 수립
강지훈
2020
29
Dissertation
이리노테칸 항암 요법 시행 후 진행한 전이성 췌장암 환자에서 리포좀 이리노테칸 및 플루오로우라실/류코보린 병합 요법에 대한 연구
방경혜
2020
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide